Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gilead Sciences
Biotech
JPM26, Day 3: Hundreds attend Biotech CEO Sisterhood meetup
Our reporters and editors are on the ground in San Francisco and will keep you updated with all the latest.
Gabrielle Masson
,
Darren Incorvaia
,
James Waldron
,
Ben Adams
Jan 14, 2026 3:34pm
JPM26: Gilead eyes new deals from a 'position of strength'
Jan 14, 2026 3:30am
Study finds HIV can evolve to resist lenacapavir—at a cost
Jan 7, 2026 2:00pm
Gilead garners lipid package for cancer asset in $300M pact
Jan 6, 2026 7:00am
AbbVie, Gilead gift themselves clinical-stage cancer drugs
Jan 2, 2026 10:35am
Gilead pays $35M to license pair of HSV assets from Assembly Bio
Dec 22, 2025 10:35am
